Spots Global Cancer Trial Database for brentuximab vedotin 50 mg [adcetris]
Every month we try and update this database with for brentuximab vedotin 50 mg [adcetris] cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma | NCT05595447 | Hodgkin Lymphom... Refractory Hodg... Relapsed Hodgki... | Brentuximab Ved... | 15 Years - 90 Years | Hospital Regional de Alta Especialidad del Bajio |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
